Valeria Clemente

Colectomy rate in acute severe ulcerative colitis in the infliximab era

Annalisa Aratari, Claudio Papi, Valeria Clemente et al. · Digestive and Liver Disease · 2008 · 194 citations

Medicine, Immunology, Surgery +16

Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study

Antonio Tursi, Giammarco Mocci, Leonardo Allegretta et al. · Inflammatory Bowel Diseases · 2022 · 29 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years. Has something changed?

Valeria Clemente, Annalisa Aratari, Claudio Papi et al. · Digestive and Liver Disease · 2016 · 21 citations

Medicine, Surgery, Gastroenterology +6

Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter?

Federica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni et al. · PubMed · 2013 · 17 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy

Antonio Tursi, Giammarco Mocci, Antonio Cuomo et al. · Journal of Gastrointestinal and Liver Diseases · 2022 · 15 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16